BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 25, 2021
View Archived Issues
Engineered ACE2 protects against SARS-CoV-2 infection in vivo
Read More
Lilly describes new GIPR and GLP-1 receptor agonists
Read More
New PTPN11 inhibitors identified at Medshine Discovery
Read More
Zhejiang Hisun Pharmaceutical patents TYK2/JAK-1/JAK-2/JAK-3 inhibitors
Read More
Incyte discovers GTPase KRAS mutant inhibitors
Read More
KalVista presents structure and preclinical data for pKA inhibitor KVD-001
Read More
New dual orexin receptor agonists for the treatment of orexin-deficient disorders such as narcolepsy
Read More
Study of MAPT-mutated cerebral organoids reveals mechanisms of glutamatergic cortical neuronal death
Read More
STING signaling identified as a therapeutic target for Niemann-Pick disease type C
Read More
FDA clears IND for phase II study of CardiolRx for acute myocarditis
Read More
Bio-Path receives IND clearance for phase I/Ib study of BP-1002 in relapsed or refractory AML
Read More
EOM initiates phase I/IIa study of EOM-613 in hospitalized COVID-19 patients
Read More
Stachydrine-leonurine conjugate SL-06 ameliorates experimental cerebral ischemic stroke
Read More
Ascletis completes bridging study and opens Chinese phase II trial of ASC-42 for chronic hepatitis B
Read More
Adjuvance reports interim phase I data on next-generation saponin adjuvant TQL-1055
Read More
Anti-CFH antibodies determine the outcome in primary membranous nephropathy
Read More
Serodus initiates phase II/III study of SER-150 in diabetic kidney disease
Read More
Phase II trial of roxadustat for chemotherapy-induced anemia meets primary efficacy endpoint
Read More
Ultragenyx opens enrollment in adaptive study of UX-701 in Wilson's disease
Read More
Moving side chains amps up peptides' infection-fighting abilities
Read More